The Relationship Between Plasma and Brain Quinolinic Acid Levels and the Severity of Hepatic Encephalopathy in Animal Models of Fulminant Hepatic Failure

Anthony S. Basile, Kuniaki Saito, Yong Li, Melvyn P. Heyes

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Abstract: Quinolinic acid is an excitatory, neurotoxic tryptophan metabolite proposed to play a role in the pathogenesis of hepatic encephalopathy. This involvement was investigated in rat and rabbit models of fulminant hepatic failure at different stages of hepatic encephalopathy. Although plasma and brain tryptophan levels were significantly increased in all stages of hepatic encephalopathy, quinolinic acid levels increased three‐ to sevenfold only in the plasma, CSF, and brain regions of animals in stage IV hepatic encephalopathy. Plasma‐CSF and plasma‐brain quinolinic acid levels in rats and rabbits with fulminant hepatic failure were strongly correlated, with CSF and brain concentrations ∼10% those of plasma levels. Moreover, there was no significant regional difference in brain quinolinic acid concentrations in either model. Extrahepatic indoleamine‐2,3‐dioxygenase activity was not altered in rats in stage IV hepatic encephalopathy, but hepatic l‐tryptophan‐2,3‐dioxygenase activity was increased. These results suggest that quinolinic acid synthesized in the liver enters the plasma and then accumulates in the CNS after crossing a permeabilized blood‐brain barrier in the end stages of liver failure. Furthermore, the observation of low brain concentrations of quinolinic acid only in stage IV encephalopathy suggests that the contribution of quinolinic acid to the pathogenesis of hepatic encephalopathy in these animal models is minor.

Original languageEnglish
Pages (from-to)2607-2614
Number of pages8
JournalJournal of Neurochemistry
Volume64
Issue number6
DOIs
Publication statusPublished - 01-01-1995
Externally publishedYes

Fingerprint

Quinolinic Acid
Hepatic Encephalopathy
Acute Liver Failure
Brain
Animals
Animal Models
Plasmas
Rats
Tryptophan
Liver
Rabbits
Liver Failure
Brain Diseases
Metabolites
Observation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

@article{609d37f8c6a143aaa9d8029f78753aa5,
title = "The Relationship Between Plasma and Brain Quinolinic Acid Levels and the Severity of Hepatic Encephalopathy in Animal Models of Fulminant Hepatic Failure",
abstract = "Abstract: Quinolinic acid is an excitatory, neurotoxic tryptophan metabolite proposed to play a role in the pathogenesis of hepatic encephalopathy. This involvement was investigated in rat and rabbit models of fulminant hepatic failure at different stages of hepatic encephalopathy. Although plasma and brain tryptophan levels were significantly increased in all stages of hepatic encephalopathy, quinolinic acid levels increased three‐ to sevenfold only in the plasma, CSF, and brain regions of animals in stage IV hepatic encephalopathy. Plasma‐CSF and plasma‐brain quinolinic acid levels in rats and rabbits with fulminant hepatic failure were strongly correlated, with CSF and brain concentrations ∼10{\%} those of plasma levels. Moreover, there was no significant regional difference in brain quinolinic acid concentrations in either model. Extrahepatic indoleamine‐2,3‐dioxygenase activity was not altered in rats in stage IV hepatic encephalopathy, but hepatic l‐tryptophan‐2,3‐dioxygenase activity was increased. These results suggest that quinolinic acid synthesized in the liver enters the plasma and then accumulates in the CNS after crossing a permeabilized blood‐brain barrier in the end stages of liver failure. Furthermore, the observation of low brain concentrations of quinolinic acid only in stage IV encephalopathy suggests that the contribution of quinolinic acid to the pathogenesis of hepatic encephalopathy in these animal models is minor.",
author = "Basile, {Anthony S.} and Kuniaki Saito and Yong Li and Heyes, {Melvyn P.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1046/j.1471-4159.1995.64062607.x",
language = "English",
volume = "64",
pages = "2607--2614",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

The Relationship Between Plasma and Brain Quinolinic Acid Levels and the Severity of Hepatic Encephalopathy in Animal Models of Fulminant Hepatic Failure. / Basile, Anthony S.; Saito, Kuniaki; Li, Yong; Heyes, Melvyn P.

In: Journal of Neurochemistry, Vol. 64, No. 6, 01.01.1995, p. 2607-2614.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Relationship Between Plasma and Brain Quinolinic Acid Levels and the Severity of Hepatic Encephalopathy in Animal Models of Fulminant Hepatic Failure

AU - Basile, Anthony S.

AU - Saito, Kuniaki

AU - Li, Yong

AU - Heyes, Melvyn P.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Abstract: Quinolinic acid is an excitatory, neurotoxic tryptophan metabolite proposed to play a role in the pathogenesis of hepatic encephalopathy. This involvement was investigated in rat and rabbit models of fulminant hepatic failure at different stages of hepatic encephalopathy. Although plasma and brain tryptophan levels were significantly increased in all stages of hepatic encephalopathy, quinolinic acid levels increased three‐ to sevenfold only in the plasma, CSF, and brain regions of animals in stage IV hepatic encephalopathy. Plasma‐CSF and plasma‐brain quinolinic acid levels in rats and rabbits with fulminant hepatic failure were strongly correlated, with CSF and brain concentrations ∼10% those of plasma levels. Moreover, there was no significant regional difference in brain quinolinic acid concentrations in either model. Extrahepatic indoleamine‐2,3‐dioxygenase activity was not altered in rats in stage IV hepatic encephalopathy, but hepatic l‐tryptophan‐2,3‐dioxygenase activity was increased. These results suggest that quinolinic acid synthesized in the liver enters the plasma and then accumulates in the CNS after crossing a permeabilized blood‐brain barrier in the end stages of liver failure. Furthermore, the observation of low brain concentrations of quinolinic acid only in stage IV encephalopathy suggests that the contribution of quinolinic acid to the pathogenesis of hepatic encephalopathy in these animal models is minor.

AB - Abstract: Quinolinic acid is an excitatory, neurotoxic tryptophan metabolite proposed to play a role in the pathogenesis of hepatic encephalopathy. This involvement was investigated in rat and rabbit models of fulminant hepatic failure at different stages of hepatic encephalopathy. Although plasma and brain tryptophan levels were significantly increased in all stages of hepatic encephalopathy, quinolinic acid levels increased three‐ to sevenfold only in the plasma, CSF, and brain regions of animals in stage IV hepatic encephalopathy. Plasma‐CSF and plasma‐brain quinolinic acid levels in rats and rabbits with fulminant hepatic failure were strongly correlated, with CSF and brain concentrations ∼10% those of plasma levels. Moreover, there was no significant regional difference in brain quinolinic acid concentrations in either model. Extrahepatic indoleamine‐2,3‐dioxygenase activity was not altered in rats in stage IV hepatic encephalopathy, but hepatic l‐tryptophan‐2,3‐dioxygenase activity was increased. These results suggest that quinolinic acid synthesized in the liver enters the plasma and then accumulates in the CNS after crossing a permeabilized blood‐brain barrier in the end stages of liver failure. Furthermore, the observation of low brain concentrations of quinolinic acid only in stage IV encephalopathy suggests that the contribution of quinolinic acid to the pathogenesis of hepatic encephalopathy in these animal models is minor.

UR - http://www.scopus.com/inward/record.url?scp=0029021470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029021470&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.1995.64062607.x

DO - 10.1046/j.1471-4159.1995.64062607.x

M3 - Article

C2 - 7760040

AN - SCOPUS:0029021470

VL - 64

SP - 2607

EP - 2614

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -